Cookie Notice

We use cookies to make parts of our website work, and to improve your visitor experience.
If you only allow necessary cookies, some features of our website may not work.

Engineering and COVID-19

Transmission of COVID-19 and the Role of Engineering

Professor Cath Noakes, of the University of Leeds, a Fellow of the Institution of Mechanical Engineers and a meber of SAGE, thee government's Scientific Advisory Group for Emergencies, explores the means by which COVIC-19 infection is transmitted and the part that engineering can play in mitigating this.

DIY Engineering and its response to the COVID-19 pandemic

Stephen McEvoy, founder of Furness 3D Printing, discusses how he adopted a new hobby and started a new business in response to COVID-19. He'll be discussing the benefits of additive manufacturing, the technical aspects of manufacturing safety visors, the ethics of producing safety equipment with minimal testing, and future opportunities for engineers to help in a national crisis. Speaker Bio: Stephen McEvoy is a Systems Engineer at Sellafield Ltd. who, in the midst of the COVID-19 pandemic, adopted a new hobby and began to put it to use in the production of safety visors for frontline workers.

UCL Ventura: The Engineering Story

Organised by the Institution’s Greater London Region, hear insights on UCL's Ventura Project from Tim Baker at UCL, together with the technical details about the Mark II device, which has received MHRA regulatory approval A collaboration between UCL, UCH and Mercedes-AMG HPP, engineers worked round-the-clock to reverse engineer a ventilator device for COVID-19 patients that could be manufactured rapidly by the thousand. The results of this joint project are already making a big impact. UCLH critical care consultant Professor Mervyn Singer (UCL Medicine) said: “In the past few weeks we have seen the UCL-Ventura help dozens of patients with Covid-19 breathe more easily.”

The COVID-19 Vaccine Supply Chain: Overcoming the challenges and complexities

How does a vaccine get manufactured? How does it get to the patients who need it? The pressure to deliver a safe, effective vaccine is immense in the current COVID-19 climate. We need strong, reliable, and safe supply to meet patients’ needs. This webinar will outline the complex journey of manufacturing a vaccine and explore the challenges in the cold chain logistics needed to deliver it. François Meurice of GSK will examine the process of transforming raw materials into syringe-ready vaccines in the factory, including the time, quality criticality, and differences from a regular drug. Following this, leading global cold chain expert Toby Peters will look at distribution from factory door to patient, and the challenges inherent to keeping the vaccine at 2-8°C throughout - or at even lower temperatures as is the case with the Pfizer/BioNTech vaccine. These sessions will encourage our engineers to better understand, amongst other things, the impacts of complex manufacturing, geographical location, scale of distribution as dependent on country government choices of vaccination programmes and data management to adequately track products in the supply chain. Finally, François and Toby hosts a live Q&A session taking audience questions submitted during the webinar.

© 2011 Institution of Mechanical Engineers. IMechE is a registered charity in England and Wales number 206882